Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a terminology change from “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:40:43.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T15:39:03.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T15:43:43.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study page now loads a 403 Forbidden error, replacing the study record content. Access to trial details, documents, and related information is no longer available on the page.
    Difference
    19%
    Check dated 2026-09-20T22:16:52.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page indicates a revision update from v3.6.5 to v3.6.6, signaling a minor software or content-management system update.
    Difference
    0.0%
    Check dated 2026-08-30T21:51:09.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    New page revision label added: v3.6.5 replaces v3.6.4. This indicates an administrative update to the page version, not a change to the study details or available actions.
    Difference
    0.0%
    Check dated 2026-08-09T09:10:21.000Z thumbnail image

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.